LOGO
Print this page | Exit  
ASTHMA AND COPD: MECHANISM OF ACTION OF GLUCOCORTICOIDS, β2-AGONISTS AND THEIR COMBINATION
mainBullet
 
mainBullet
Introduction
 
mainBullet
 
mainBullet
mainBullet
mainBullet
mainBullet
References
 

 

References
References
1.
Johnson, M. Interactions between Corticosteroids and β2-Agonists in Asthma and Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 2004; 1: 200- 206.
2. Global Initiative for Asthma (GINA) guidelines, 2005 up-date.
3. Rhen, T. and Cidlowski, J. A. Antiinflammatory Actions of Glucocorticoids-New Mechanisms for old Drugs. NEJM 2005; 353: 1711-1723.
4. Barnes, P. J. Molecular Mechanisms and Cellular effects of Glucocorticosteroids. Immunol Allergy Clin N Am 2005; 25: 451-468.
5. Barnes, P. J. and Stockley, R. A. COPD: current therapeutic interventions and future approaches. Eur Respir J 2005; 25: 1084-1106.
6. Johnson, M. Molecular mechanisms of β2-adrenergic receptor function, response, and regulation. J Allergy Clin Immunol 2006; 117: 18-24.
7. Barnes, P. J. Scientific rationale for inhaled combination therapy with long-acting β2-agonists and corticosteroids. Eur Respir J 2002; 19: 182-191.
8. Hansel, T. T. and Barnes, P. J. An Atlas of Chronic Obstructive Pulmonary Disease-COPD. 2004.
9. Mak, J.C. Glucocorticosteroids increase β2-adrenergic receptor transcription in human lung. Am J Physiol 1995; 12: L41-L46.
10. Mak, J.C. Protective effects of a glucocorticoid on down-regulation of pulmonary β2-adrenergic receptors in vivo. J Clin Invest 1995; 96: 99-106.
11. Baraniuk, J.N. Glucocorticoids induce β2-adrenergic receptor function in human nasal mucosa. Am J Respir Crit Care Med 1997; 155: 704-710.
12. Chong, L.K. Beta-adrenoceptor reserve in human lung: a comparison between airway smooth muscle and mast cells. Eur J Pharmacol 1999; 378: 115-122.
13. Adcock, I.M. Effects of LABA on GR function: possible role of GR phosphorylation. J Allergy Clin Immunol 2002; 110: S261-S268.
14. Eickelberg, O. Ligand-independent activation of the glucocorticoid receptor by β2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J Biol Chem 1999; 274: 1005-1010.
15. Usmani, O.S. Glucocorticoid receptor activation following inhaled fluticasone and salmeterol. Am J Resp Crit Care Med 2002; 165: A618.
16. Profita, M. Biochemical interaction between effects of beclomethasone dipropionate and salbutamol or formoterol in sputum cells from mild to moderate asthmatics. Allergy 2005: 60: 323–329.
17. Barnes, N.C. Anti-inflammatory Effects of Salmeterol/Fluticasone Propionate in Chronic Obstructive Disease. Am J Respir Crit Care Med. 2006; 173: 736-743.
18. Pauwels, R. A. et al., N Engl J Med 1997; 1405-1411.
19. Zetterström, O. et al., Eur Respir J 2001; 18: 262-268.
20. Umesh, G. et al., Chest 2003; 1480-1487.
21. Calverley, P. M. et al., Eur Respir J 2003; 22: 912-919.
22. Szafranski, W. et al., Eur Respir J 2003; 21: 74-81.
23. Mahler, D. A. et al., Am J Respir Crit Care Med 2002; 166: 1084-1091.
24. Hanania, N. A. et al., Chest 2003; 124: 834-843.
25. Calverley, P. M. et al., The Lancet 2003; 361: 449-456.
26 Calverley P.M. et al, N Engl J Med 2007; 356 : 775-789

 

IMI logo